Aspire Biopharma Holdings Inc

NAS:ASBPHealthcarenasdaq_composite

$8.80−1.12%LiveIn session · ≈ AED 32.32 · Market cap $12.34M

ASBP · Ratios · TradingHolo

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	—	—	—	—	−1.9%	—	—
Operating margin	—	—	—	—	−312,016.9%	−312,016.9%	+0.0 pts
Net margin	—	—	—	—	−394,725.1%	−394,725.1%	+0.0 pts
EBITDA margin	—	—	—	—	−182,712.7%	—	—
Return on equity	5,363.2%	1.2%	22.8%	814.0%	383.9%	383.9%	+0.0 pts
Return on assets	−8.7%	1.1%	22.3%	−8,471.6%	−1,865.7%	−1,865.7%	+0.0 pts
Return on capital employed	5,364.2%	−0.3%	−6.8%	200.6%	308.1%	—	—
Debt / equity	−502.3×	0.0×	0.0×	−0.8×	−0.2×	−0.2×	+0.0%
Debt / assets	81.4%	0.0%	0.1%	856.0%	105.5%	—	—
Interest coverage	0.0×	0.0×	−149.5×	3.5×	−2.3×	—	—
Current ratio	1.0×	3.6×	0.2×	0.1×	0.2×	0.2×	+0.0%
Quick ratio	1.0×	3.6×	0.2×	0.1×	0.1×	—	—
Cash ratio	0.0×	1.6×	0.0×	0.0×	0.1×	0.1×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Inventory turnover	—	—	—	—	0.0×	—	—
Receivables turnover	—	—	—	0.0×	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.